Clenbuterol

Clenbuterol

SCHEMBL123545

CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1.Cl

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB2

The experimentally established mechanism targets of Clenbuterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 3/20 0.97
LMNA P02545 4/20 1.00
CYP3A4 P08684 2/20 1.00
KDM4E B2RXH2 2/20 1.00
ADRB1 P08588 5/20 0.97
TSHR P16473 2/20 0.97
HTR1A P08908 1/20 0.97
SLC6A2 P23975 1/20 0.97
SLC6A4 P31645 1/20 0.97
ADRA1A P35348 1/20 0.97
OPRK1 P41145 1/20 0.97
SLC6A3 Q01959 1/20 0.97
HIF1A Q16665 3/20 0.58
CASP7 P55210 2/20 0.58
KMT2A Q03164 2/20 0.58
CYP2C9 P11712 1/20 0.58
BLM P54132 2/20 0.53
CASP1 P29466 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Clenbuterol SCHEMBL28145163 1.00 LMNA (1.00) LMNACYP3A4KDM4EADRB1ADRB2
Clenbuterol SCHEMBL4723 0.98 ADRB1 (1.00) LMNACYP3A4KDM4EADRB1ADRB2
Clenbuterol SCHEMBL20761507 0.98 ADRB1 (1.00) LMNACYP3A4KDM4EADRB1ADRB2
Clenbuterol SCHEMBL4722 0.98 ADRB1 (1.00) LMNACYP3A4KDM4EADRB1ADRB2
Clenbuterol SCHEMBL27992618 0.95 ADRB1 (0.94) LMNACYP3A4KDM4EADRB1ADRB2
Clenbuterol SCHEMBL10614465 0.91 LMNA (0.86) LMNACYP3A4KDM4EADRB1ADRB2
Hydrochloric Acid SCHEMBL10887306 0.90 LMNA (0.81) LMNACYP3A4KDM4EADRB1ADRB2
Hydrochloric Acid SCHEMBL10614323 0.90 LMNA (0.81) LMNACYP3A4KDM4EADRB1ADRB2
SCHEMBL30083793 0.88 ADRB1 (0.81) LMNACYP3A4KDM4EADRB1ADRB2
SCHEMBL10614327 0.88 ADRB1 (0.81) LMNACYP3A4KDM4EADRB1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4531 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070909-A Ambroxol anhydrous swallow granule and preparation method thereof 华益泰康药业股份有限公司 2026-05-22 CN claimed
EP-4649960-A1 USE OF LONG-ACTING ß2AR AGONIST IN PREPARATION OF DRUGS FOR TREATING CANCERS Hong Kong Sxmeterol Pharmaceutical Co., Limited (HK) 2025-11-19 EP claimed
CN-115015548-B Double-mode detection clenbuterol hydrochloride Luo Shizhi strip constructed by natural nanoparticles of cuttlefish juice and application thereof 西北农林科技大学 2025-05-30 CN claimed
CN-120001419-A Silicon-based bimetallic nano-enzyme for high-sensitivity detection of various environmental pollutants and preparation method and application thereof 中国科学院合肥物质科学研究院 2025-05-16 CN claimed
CN-119950419-A Preparation process of ambroxol oral liquid 苏州弘森药业股份有限公司 2025-05-09 CN claimed
CN-222838074-U Clenbuterol hydrochloride detection card 武汉上成生物科技有限公司 2025-05-06 CN claimed
CN-115219715-B Micro-cantilever beam sensing detection method based on magnetic force enhancement 中国科学技术大学 2025-04-11 CN claimed
CN-119738559-A Multi-antibody integrated polymerization probe, test strip for detecting clenbuterol residue, preparation method, device and method thereof 中国农业大学 2025-04-01 CN claimed
CN-119534827-A Double-quantum dot microsphere fluorescence immunochromatography kit for detecting clenbuterol and ractopamine, and preparation method and detection method thereof 中国农业科学院农业质量标准与检测技术研究所 2025-02-28 CN claimed
CN-114397150-B System and method for detecting clenbuterol residue 宁波华仪宁创智能科技有限公司 2025-02-25 CN claimed
EP-0580860-B1 METHOD OF MANUFACTURING SOLID DISPERSION NIPPON SHINYAKU CO LTD (JP) 1997-10-22 EP claimed
CN-1133004-A Method for regulating substances ASTRA AB (SE) 1996-10-09 CN claimed
EP-0717616-A1 PROCESS FOR CONDITIONING SUBSTANCES Astra Aktiebolag (SE) 1996-06-26 EP claimed
WO-1995005805-A1 PROCESS FOR CONDITIONING SUBSTANCES ASTRA AKTIEBOLAG (SE) 1995-03-02 WO claimed
CN-1088819-A Anti-asthmatic tablets and preparation method thereof BEIFANG PHARMACEUTIC PLANT SHA (CN) 1994-07-06 CN claimed
EP-0227836-B1 SUSTAINED RELEASING PATCH TEIJIN LIMITED (JP) 1991-12-27 EP claimed
US-4801458-A POROUS HOLLOW FIBERS FILLED WITH MEDICINE TEIJIN LIMITED (JP) 1989-01-31 US claimed
EP-0227836-A1 SUSTAINED RELEASING PATCH TEIJIN LIMITED (JP) 1987-07-08 EP claimed
EP-0026298-B1 METHOD FOR PROMOTING GROWTH AND REDUCING FAT IN ANIMALS USING PHENYLETHANOLAMINE DERIVATIVES AMERICAN CYANAMID COMPANY (US) 1984-04-18 EP claimed
EP-0026298-A1 Method for promoting growth and reducing fat in animals using phenylethanolamine derivatives AMERICAN CYANAMID COMPANY (US) 1981-04-08 EP claimed